Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 200 articles:
HTML format
Text format



Single Articles


    March 2017
  1. METHAWASIN M, Granzier H
    Response by Methawasin and Granzier to Letter Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection F
    Circulation. 2017;135:e681-e682.
    PubMed     Text format    


  2. LEWIS GA, Miller CA
    Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2017;135:e679-e680.
    PubMed     Text format    


  3. SUNDSTROM J, Bruze G, Ottosson J, Marcus C, et al
    Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.
    Circulation. 2017 Mar 3. pii: CIRCULATIONAHA.116.025629.
    PubMed     Text format     Abstract available


  4. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    PubMed     Text format     Abstract available


    February 2017
  5. KONSTAM MA, Abboud FM
    Ejection Fraction: Misunderstood and Overrated (Changing the Paradigm in Categorizing Heart Failure).
    Circulation. 2017;135:717-719.
    PubMed     Text format    


  6. CHRISTIANSEN MN, Kober L, Weeke P, Vasan RS, et al
    Age-specific Trends in Incidence, Mortality and Comorbidities of Heart Failure in Denmark 1995-2012.
    Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.025941.
    PubMed     Text format     Abstract available


  7. TIBURCY M, Hudson JE, Balfanz P, Schlick SF, et al
    Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair.
    Circulation. 2017 Feb 6. pii: CIRCULATIONAHA.116.024145.
    PubMed     Text format     Abstract available


  8. SELIGER SL, Hong SN, Christenson RH, Kronmal R, et al
    High Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.116.025505.
    PubMed     Text format     Abstract available


  9. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Text format     Abstract available


    January 2017
  10. SAIKI H, Petersen IA, Scott CG, Bailey KR, et al
    Risk of Heart Failure with Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.
    Circulation. 2017 Jan 29. pii: CIRCULATIONAHA.116.025434.
    PubMed     Text format     Abstract available


  11. PENG D, Zhang Y, Rosenthal DN, Palmon M, et al
    Impact of Heart Transplantation on the Functional Status of U.S. Children with End-Stage Heart Failure. Analysis of Data from the Organ Procurement and Transplantation Network.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.115.016520.
    PubMed     Text format     Abstract available


  12. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    PubMed     Text format    


  13. NARAYAN HK, Finkelman BS, French B, Plappert T, et al
    Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations with Ejection Fraction Decline, Recovery, and Heart Failure Symptoms over 3 Years of Followup.
    Circulation. 2017 Jan 19. pii: CIRCULATIONAHA.116.023463.
    PubMed     Text format     Abstract available


  14. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
    Circulation. 2017;135:e22-e23.
    PubMed     Text format    


  15. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
    Circulation. 2017;135:e20-e21.
    PubMed     Text format    


  16. ELLINGSEN O, Halle M, Conraads VM, Stoylen A, et al
    High Intensity Interval Training in Heart Failure Patients with Reduced Ejection Fraction.
    Circulation. 2017 Jan 12. pii: CIRCULATIONAHA.116.022924.
    PubMed     Text format     Abstract available


  17. SEIDEL T, Navankasattusas S, Ahmad AA, Diakos NA, et al
    Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.
    Circulation. 2017 Jan 10. pii: CIRCULATIONAHA.116.024470.
    PubMed     Text format     Abstract available


  18. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    PubMed     Text format     Abstract available


    December 2016
  19. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    PubMed     Text format     Abstract available


  20. ABU-TAHA IH, Heijman J, Hippe HJ, Wolf NM, et al
    Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.022852.
    PubMed     Text format     Abstract available


    November 2016
  21. NADRUZ W JR, Claggett BL, McMurray JJ, Packer M, et al
    Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pros
    Circulation. 2016;134:1785-1787.
    PubMed     Text format    


  22. SHAH AM, Claggett B, Loehr LR, Chang PP, et al
    Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.023361.
    PubMed     Text format     Abstract available


  23. PACKER M
    Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective.
    Circulation. 2016;134:1664-1678.
    PubMed     Text format     Abstract available


  24. MEHRA MR, Lindenfeld J
    Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016.
    Circulation. 2016;134:1505-1506.
    PubMed     Text format    


  25. MCKELLAR SH, Fang JC
    An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
    Circulation. 2016;134:1325-1327.
    PubMed     Text format    


    October 2016
  26. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


  27. LEWINTER MM, Zile MR
    Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;134:1100-1104.
    PubMed     Text format    


  28. METHAWASIN M, Strom JG, Slater RE, Fernandez V, et al
    Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2016;134:1085-1099.
    PubMed     Text format     Abstract available



  29. Correction to: Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?
    Circulation. 2016;134:e307.
    PubMed     Text format    


  30. COWIE MR
    Returning to Work: A Forgotten Aspect of Rehabilitation for Heart Failure.
    Circulation. 2016;134:1010-1012.
    PubMed     Text format    


    September 2016

  31. Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart As
    Circulation. 2016;134:e298.
    PubMed     Text format    


  32. MELGARI D, Ng GA, Hancox JC
    Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium".
    Circulation. 2016;134:e296-7.
    PubMed     Text format    



  33. Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e261.
    PubMed     Text format    


  34. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
    Circulation. 2016;134:e189-90.
    PubMed     Text format    


  35. SKOLNIK N
    Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e187-8.
    PubMed     Text format    


  36. LIU W, Yang XJ
    Letter from Liu and Yang Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e185-6.
    PubMed     Text format    


  37. KOSIUK J, Hindricks G, Bollmann A
    Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e183-4.
    PubMed     Text format    


  38. WILLEY JZ, Biviano A
    Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e181-2.
    PubMed     Text format    


  39. TURCO P
    Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e179-80.
    PubMed     Text format    


    August 2016
  40. PACKER M
    Heart Failure's Dark Secret: Does Anyone Really Care About Optimal Medical Therapy?
    Circulation. 2016;134:629-31.
    PubMed     Text format    


  41. PETRIE MC, Jhund PS, She L, Adlbrecht C, et al
    Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)
    Circulation. 2016 Aug 29. pii: CIRCULATIONAHA.116.024800.
    PubMed     Text format     Abstract available


  42. RORTH R, Wong C, Kragholm K, Fosbol E, et al
    Return to the Workforce Following First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study.
    Circulation. 2016 Aug 9. pii: CIRCULATIONAHA.116.021859.
    PubMed     Text format     Abstract available


  43. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    PubMed     Text format    


  44. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    PubMed     Text format    


  45. SHIRAKABE A, Zhai P, Ikeda Y, Saito T, et al
    Response by Shirakabe et al to Letter Regarding Article, "Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure".
    Circulation. 2016;134:e75-6.
    PubMed     Text format    


  46. PAPALIA F, Okonko DO
    Letter by Papalia and Okonko Regarding Article, "Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure".
    Circulation. 2016;134:e73-4.
    PubMed     Text format    


  47. FANG JC
    Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?
    Circulation. 2016;134:435-7.
    PubMed     Text format    


  48. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.
    Circulation. 2016 Aug 4. pii: CIRCULATIONAHA.115.021048.
    PubMed     Text format     Abstract available


  49. LEE CF, Chavez JD, Garcia-Menendez L, Choi YS, et al
    Normalization of NAD+ Redox Balance as a Therapy for Heart Failure.
    Circulation. 2016 Aug 3. pii: CIRCULATIONAHA.116.022495.
    PubMed     Text format     Abstract available


    July 2016
  50. TAEGTMEYER H
    Failing Heart and Starving Brain: Ketone Bodies to the Rescue.
    Circulation. 2016;134:265-6.
    PubMed     Text format    


  51. RAJAPAKSE NW, Kuruppu S, Ian Smith A
    Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e9-e10.
    PubMed     Text format    


  52. HUBERS SA, Brown NJ
    Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e11-2.
    PubMed     Text format    


  53. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  54. PAGE RL 2ND, O'Bryant CL, Cheng D, Dow TJ, et al
    Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Jul 11. pii: CIR.0000000000000426.
    PubMed     Text format     Abstract available


  55. SHAH SJ, Kitzman DW, Borlaug BA, van Heerebeek L, et al
    Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Circulation. 2016;134:73-90.
    PubMed     Text format     Abstract available


  56. EL-JAWAHRI A, Paasche-Orlow MK, Matlock D, Stevenson LW, et al
    Randomized, Controlled Trial of an Advance Care Planning Video Decision Support Tool for Patients With Advanced Heart Failure.
    Circulation. 2016;134:52-60.
    PubMed     Text format     Abstract available


    June 2016
  57. UDELSON JE, Stevenson LW
    The Future of Heart Failure Diagnosis, Therapy, and Management.
    Circulation. 2016;133:2671-86.
    PubMed     Text format    


  58. LOW WANG CC, Hess CN, Hiatt WR, Goldfine AB, et al
    Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.
    Circulation. 2016;133:2459-502.
    PubMed     Text format     Abstract available


  59. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e692-3.
    PubMed     Text format    


  60. PROVIDENCIA R, Lambiase PD
    Letter by Providencia and Lambiase Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e691.
    PubMed     Text format    


    May 2016
  61. PSOTKA MA, Teerlink JR
    Ivabradine: Role in the Chronic Heart Failure Armamentarium.
    Circulation. 2016;133:2066-75.
    PubMed     Text format     Abstract available


  62. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Cl
    Circulation. 2016 May 20. pii: CIR.0000000000000435.
    PubMed     Text format    


  63. ANTMAN EM, Bax J, Chazal RA, Creager MA, et al
    Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
    Circulation. 2016 May 20. pii: CIR.0000000000000436.
    PubMed     Text format    


  64. MCMURRAY JJ
    Disease Management Programs in Cardiology: Extending the Success in Failure.
    Circulation. 2016;133:1836-7.
    PubMed     Text format    


    April 2016
  65. DESAI AS
    Intensive Management to Reduce Hospitalizations in Patients With Heart Failure.
    Circulation. 2016;133:1704-7.
    PubMed     Text format    


  66. SUNDARAM V, Fang JC
    Gastrointestinal and Liver Issues in Heart Failure.
    Circulation. 2016;133:1696-703.
    PubMed     Text format     Abstract available


  67. OKUMURA N, Jhund PS, Gong J, Lefkowitz MP, et al
    Importance of Clinical Worsening of Heart Failure Treated in the Outpatient Setting: Evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF).
    Circulation. 2016 Apr 20. pii: CIRCULATIONAHA.115.020729.
    PubMed     Text format     Abstract available


  68. PAL N, Sivaswamy N, Mahmod M, Yavari A, et al
    Response to Letter Regarding Article, "The Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;133:e604.
    PubMed     Text format    


  69. DE DIOS S
    Letter by de Dios Regarding Article, "Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;133:e603.
    PubMed     Text format    


  70. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  71. SUN H, Olson KC, Gao C, Prosdocimo DA, et al
    Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.
    Circulation. 2016 Apr 8. pii: CIRCULATIONAHA.115.020226.
    PubMed     Text format     Abstract available


  72. ARANY Z, Elkayam U
    Peripartum Cardiomyopathy.
    Circulation. 2016;133:1397-409.
    PubMed     Text format     Abstract available


    March 2016
  73. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.115.019406.
    PubMed     Text format     Abstract available


  74. KOPLAN BA, Stevenson WG
    Atrial Fibrillation in Heart Failure: Should Catheter Ablation Play a Larger Role?
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.116.022261.
    PubMed     Text format     Abstract available


  75. MIYAMOTO S, Brown JH
    Drp1 and Mitochondrial Autophagy Lend a Helping Hand in Adaptation to Pressure Overload.
    Circulation. 2016;133:1225-7.
    PubMed     Text format    


  76. HUBERS SA, Brown NJ
    Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation. 2016;133:1115-24.
    PubMed     Text format     Abstract available


  77. BENARD L, Oh JG, Cacheux M, Lee A, et al
    Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.
    Circulation. 2016 Mar 2. pii: CIRCULATIONAHA.115.020678.
    PubMed     Text format     Abstract available


    February 2016
  78. SHIRAKABE A, Zhai P, Ikeda Y, Saito T, et al
    Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure-Overload-Induced Mitochondrial Dysfunction and Heart Failure.
    Circulation. 2016 Feb 25. pii: CIRCULATIONAHA.115.020502.
    PubMed     Text format     Abstract available


  79. EGBE AC, Connolly HM, Qureshi MY, Schaff HV, et al
    Surgically Constructed Double-Outlet Right Ventricle.
    Circulation. 2016;133:765-7.
    PubMed     Text format    


  80. AUBERT G, Martin OJ, Horton JL, Lai L, et al
    The Failing Heart Relies on Ketone Bodies as a Fuel.
    Circulation. 2016;133:698-705.
    PubMed     Text format     Abstract available


  81. HSU S, Kass DA
    Can Nitrite AMPk Up Sirt-ainty to Treat Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;133:692-4.
    PubMed     Text format    


  82. ECKEL RH, Hokanson JE
    The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes: Do We Just Stop Here?
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.116.021654.
    PubMed     Text format     Abstract available


  83. VISTISEN D, Andersen GS, Hansen CS, Hulman A, et al
    Prediction of First Cardiovascular Disease Event in Type 1 Diabetes: The Steno T1 Risk Engine.
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.115.018844.
    PubMed     Text format     Abstract available


  84. PRENNER SB, Franken AA, Murphy IG, Mikati IA, et al
    Rapid Reversal of Focal Left Ventricular Hypertrophy and Systolic Dysfunction Resulting From Myocardial Infiltration by Acute Lymphoblastic Leukemia.
    Circulation. 2016;133:678-9.
    PubMed     Text format    


  85. JONKMAN NH, Westland H, Groenwold RH, Agren S, et al
    Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.018006.
    PubMed     Text format     Abstract available


  86. MELMAN YF, Shah R, Danielson K, Xiao J, et al
    Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study".
    Circulation. 2016;133:e389-90.
    PubMed     Text format    


  87. SARDU C, Paolisso G, Marfella R
    Letter by Sardu et al Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study".
    Circulation. 2016;133:e388.
    PubMed     Text format    


    January 2016
  88. KOLWICZ SC JR, Airhart S, Tian R
    Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?
    Circulation. 2016 Jan 27. pii: CIRCULATIONAHA.116.021230.
    PubMed     Text format     Abstract available


  89. BEDI KC JR, Snyder NW, Brandimarto J, Aziz M, et al
    Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.
    Circulation. 2016 Jan 27. pii: CIRCULATIONAHA.115.017545.
    PubMed     Text format     Abstract available


  90. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    PubMed     Text format     Abstract available


  91. CARDINALE D, Colombo A, Bacchiani G, Tedeschi I, et al
    Response to Letters Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy".
    Circulation. 2016;133:e363.
    PubMed     Text format    


  92. GALLUCCI G, Simeon V
    Letter by Gallucci and Simeon Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy".
    Circulation. 2016;133:e362.
    PubMed     Text format    


  93. PATANE S
    Letter by Patane Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy".
    Circulation. 2016;133:e361.
    PubMed     Text format    


  94. STOUT KK, Broberg CS, Book WM, Cecchin F, et al
    Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Jan 19. pii: CIR.0000000000000352.
    PubMed     Text format    


  95. SADO DM, Kozor R, Corr L, Moon JC, et al
    Global Myocardial Edema in Antisynthetase Syndrome Detected by Cardiovascular Magnetic Resonance Mapping Techniques.
    Circulation. 2016;133:e25-6.
    PubMed     Text format    


  96. LIU PP, Smyth D
    Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.
    Circulation. 2016;133:245-7.
    PubMed     Text format    


  97. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved vs. Reduced Ejection Fraction.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.018614.
    PubMed     Text format     Abstract available


  98. AUNE D, Sen A, Norat T, Janszky I, et al
    Body Mass Index, Abdominal Fatness and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.016801.
    PubMed     Text format     Abstract available


  99. NDUMELE CE, Matsushita K, Sang Y, Lazo M, et al
    NT-proBNP and Heart Failure Risk Among Individuals With and Without Obesity: The ARIC Study.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.017298.
    PubMed     Text format     Abstract available


  100. OE H, Ohno Y, Yamanaka T, Watanabe N, et al
    Biatrial Appendage Thrombi in a Heart Failure Patient With Sinus Rhythm: Detailed Assessment by Real-Time 3-Dimensional Transesophageal Echocardiography.
    Circulation. 2016;133:e1-4.
    PubMed     Text format    


    December 2015
  101. CONNORS LH, Sam F, Skinner M, Salinaro F, et al
    Heart Failure Due to Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.
    Circulation. 2015 Dec 11. pii: CIRCULATIONAHA.115.018852.
    PubMed     Text format     Abstract available


  102. ABDUL-RAHIM AH, Perez AC, Fulton RL, Jhund PS, et al
    Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopr
    Circulation. 2015;132:e358.
    PubMed     Text format    


  103. LIN GM, Hung Y, Li YH
    Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sop
    Circulation. 2015;132:e357.
    PubMed     Text format    


    November 2015
  104. ABU DAYA H, Gheorghiade M, Schelbert EB
    Letter by Abu Daya et al Regarding Article, "Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction, Contributions of Collagen and Titin".
    Circulation. 2015;132:e248.
    PubMed     Text format    


  105. REDDY S, Bernstein D
    Molecular Mechanisms of Right Ventricular Failure.
    Circulation. 2015;132:1734-42.
    PubMed     Text format     Abstract available


    October 2015
  106. GERSTEIN HC, Pare G, McQueen MJ, Haenel H, et al
    Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia.
    Circulation. 2015 Oct 30. pii: CIRCULATIONAHA.115.015744.
    PubMed     Text format     Abstract available



  107. ECG response: October 27, 2015.
    Circulation. 2015;132:1679-80.
    PubMed     Text format    


  108. MOHAMMED SF, Redfield MM
    Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2015;132:e206.
    PubMed     Text format    


  109. CAMPBELL DJ
    Letter by Campbell Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2015;132:e205.
    PubMed     Text format    


  110. EDWARDS NC, Hayer MK, Ferro CJ
    Letter by Edwards et al Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".
    Circulation. 2015;132:e204.
    PubMed     Text format    


  111. PODRID PJ
    ECG Response: October 6, 2015.
    Circulation. 2015;132:1365.
    PubMed     Text format    


  112. WALSH MN
    Risk of Obstructive Sleep Apnea: Sex Matters.
    Circulation. 2015;132:1305-6.
    PubMed     Text format    


  113. INTWALA S, Balady GJ
    Physical Activity in the Prevention of Heart Failure: Another Step Forward.
    Circulation. 2015 Oct 5. pii: CIRCULATIONAHA.115.018831.
    PubMed     Text format     Abstract available


  114. PANDEY A, Garg S, Khunger M, Darden D, et al
    Dose Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis.
    Circulation. 2015 Oct 5. pii: CIRCULATIONAHA.115.015853.
    PubMed     Text format     Abstract available


    September 2015
  115. MOHAMMED SF, Forfia P, Redfield MM
    Response to Letter Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e161.
    PubMed     Text format    


  116. GUAZZI M
    Letter by Guazzi Regarding Article, "Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study".
    Circulation. 2015;132:e160.
    PubMed     Text format    


  117. BORLAUG BA
    Moving Beyond Cardio-Centricity in Heart Failure Risk Stratification.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.115.018951.
    PubMed     Text format     Abstract available


  118. WHITE JR, Chang CH, So-Armah KA, Stewart JC, et al
    Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.114.014443.
    PubMed     Text format     Abstract available


  119. NAJI P, Griffin BP, Sabik JF, Kusunose K, et al
    Characteristics and Outcomes of Patients With Severe Bioprosthetic Aortic Valve Stenosis Undergoing Redo Surgical Aortic Valve Replacement.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.115.015939.
    PubMed     Text format     Abstract available


  120. BERRY NC, Sobieszczyk PS, Beckman JA
    The Thrill Is Gone: A Case of Progressive Dyspnea.
    Circulation. 2015;132:953-9.
    PubMed     Text format    


  121. KITZMAN DW
    Conventional Wisdom in HF Treatment Challenged Again: Does Heart Rate Lowering Worsen Exercise Intolerance in Heart Failure with Preserved Ejection Fraction?
    Circulation. 2015 Sep 2. pii: CIRCULATIONAHA.115.018954.
    PubMed     Text format     Abstract available


  122. ASHRAFIAN H, Pal N, Sivaswamy N, Mahmod M, et al
    The Effect of Selective Heart Rate Slowing in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2015 Sep 2. pii: CIRCULATIONAHA.115.017119.
    PubMed     Text format     Abstract available


    August 2015
  123. QUEREJETA ROCA G, Redline S, Claggett B, Bello N, et al
    Sex-Specific Association of Sleep Apnea Severity with Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study.
    Circulation. 2015 Aug 27. pii: CIRCULATIONAHA.115.016985.
    PubMed     Text format     Abstract available


  124. GRANDIN EW, Jessup M
    Rethinking the Focus of Heart Failure Quality Measures.
    Circulation. 2015 Aug 27. pii: CIRCULATIONAHA.115.018692.
    PubMed     Text format     Abstract available


  125. ALLEN LA, Fonarow GC, Liang L, Schulte PJ, et al
    Medication Initiation Burden Required to Comply with Heart Failure Guideline Recommendations and Hospital Quality Measures.
    Circulation. 2015 Aug 27. pii: CIRCULATIONAHA.115.014281.
    PubMed     Text format     Abstract available


  126. WROBEL K, Stevens SR, Jones RH, Selzman CH, et al
    Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (
    Circulation. 2015;132:720-30.
    PubMed     Text format     Abstract available


  127. SCIRICA BM, Braunwald E, Raz I, Cavender MA, et al
    Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial".
    Circulation. 2015;132:e121-2.
    PubMed     Text format    


  128. MUSKIET MH, Tonneijck L, van Raalte DH
    Letter by Muskiet et al Regarding Article, "Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial".
    Circulation. 2015;132:e120.
    PubMed     Text format    


  129. MACHUCA TN, de Perrot M
    Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension.
    Circulation. 2015;132:526-36.
    PubMed     Text format    


    July 2015
  130. ZHU Z, Fu Y, Tian D, Sun N, et al
    Combination of an Immune Modulator Fingolimod with Alteplase in Acute Ischemic Stroke: A Pilot Trial.
    Circulation. 2015 Jul 22. pii: CIRCULATIONAHA.115.016371.
    PubMed     Text format     Abstract available


  131. POTUS F, Ruffenach G, Dahou A, Thebault C, et al
    Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
    Circulation. 2015 Jul 10. pii: CIRCULATIONAHA.115.016382.
    PubMed     Text format     Abstract available


  132. NAKAMURA K, Bechis MZ, Yee AJ, Dudzinski DM, et al
    Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy.
    Circulation. 2015;132:59-67.
    PubMed     Text format    


  133. CAVENDER MA, Steg PG, Smith SC, Eagle K, et al
    Impact of Diabetes on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years from the REACH Registry.
    Circulation. 2015 Jul 7. pii: CIRCULATIONAHA.114.014796.
    PubMed     Text format     Abstract available


    June 2015
  134. MENTZ RJ, Khouri MG
    Longitudinal Strain in Heart Failure with Preserved Ejection Fraction: Is There a Role for Prognostication?
    Circulation. 2015 Jun 30. pii: CIRCULATIONAHA.115.017683.
    PubMed     Text format     Abstract available


  135. SHAH AM, Claggett B, Sweitzer NK, Shah SJ, et al
    The Prognostic Importance of Impaired Systolic Function in Heart Failure with Preserved Ejection Fraction and the Impact of Spironolacton.
    Circulation. 2015 Jun 30. pii: CIRCULATIONAHA.115.015884.
    PubMed     Text format     Abstract available


  136. DORN GW 2ND
    Great Expectations: MicroRNA-30d and Cardiac Resynchronization Therapy.
    Circulation. 2015;131:2172-5.
    PubMed     Text format    


  137. GROARKE JD, Nohria A
    Anthracycline cardiotoxicity: a new paradigm for an old classic.
    Circulation. 2015;131:1946-9.
    PubMed     Text format    


    May 2015
  138. SELVIN E, Rawlings AM, Lutsey P, Maruthur N, et al
    Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Circulation. 2015 May 28. pii: CIRCULATIONAHA.115.015415.
    PubMed     Text format     Abstract available


  139. BHATT AB, Foster E, Kuehl K, Alpert J, et al
    Congenital heart disease in the older adult: a scientific statement from the American Heart Association.
    Circulation. 2015;131:1884-931.
    PubMed     Text format    


  140. MELMAN YF, Shah R, Danielson K, Xiao J, et al
    Circulating MicroRNA-30d is Associated with Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study.
    Circulation. 2015 May 20. pii: CIRCULATIONAHA.114.013220.
    PubMed     Text format     Abstract available


  141. GIVERTZ MM, Anstrom KJ, Redfield MM, Deswal A, et al
    Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
    Circulation. 2015;131:1763-71.
    PubMed     Text format     Abstract available


  142. TAMARIZ L, Hare JM
    Xanthine oxidase inhibitors in heart failure: where do we go from here?
    Circulation. 2015;131:1741-4.
    PubMed     Text format    


  143. RYAN JJ, Archer SL
    Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.
    Circulation. 2015;131:1691-702.
    PubMed     Text format    


  144. CARDINALE D, Colombo A, Bacchiani G, Tedeschi I, et al
    Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy.
    Circulation. 2015 May 6. pii: CIRCULATIONAHA.114.013777.
    PubMed     Text format     Abstract available


    April 2015
  145. DEB A, Wang Y
    Hypertrophic preconditioning: short-term tricks for long-term gain.
    Circulation. 2015;131:1468-70.
    PubMed     Text format    


  146. SALEM S, Jankowski V, Asare Y, Liehn E, et al
    Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor.
    Circulation. 2015;131:1426-34.
    PubMed     Text format     Abstract available


  147. WANG Y, Gao E, Lau WB, Wang Y, et al
    G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.
    Circulation. 2015;131:1392-404.
    PubMed     Text format     Abstract available


    March 2015
  148. ZALAWADIYA SK, Lindenfeld J, DiSalvo T
    Rapid diagnosis of cardiac tamponade using pulsatility index variability in a patient with a HeartWare ventricular assist device.
    Circulation. 2015;131:e387-8.
    PubMed     Text format    


  149. WEI X, Wu B, Zhao J, Zeng Z, et al
    Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Circulation. 2015 Mar 27. pii: CIRCULATIONAHA.114.013789.
    PubMed     Text format     Abstract available


  150. HOMMA S, Ye S
    Stroke and Anticoagulation in Heart Failure Without Atrial Fibrillation: From Risk to Opportunity.
    Circulation. 2015 Mar 25. pii: CIRCULATIONAHA.115.016329.
    PubMed     Text format     Abstract available


  151. ABDUL-RAHIM AH, Perez AC, Fulton RL, Jhund PS, et al
    Risk of Stroke in Chronic Heart Failure Patients without Atrial Fibrillation: Analysis of the CORONA and GISSI-HF Trials.
    Circulation. 2015 Mar 25. pii: CIRCULATIONAHA.114.013760.
    PubMed     Text format     Abstract available


  152. BEIGEL R, Cercek B, Siegel RJ, Hamilton MA, et al
    Echo-Doppler Hemodynamics: An Important Management Tool for Today's Heart Failure Care.
    Circulation. 2015;131:1031-4.
    PubMed     Text format    


  153. FRIELER RA, Mortensen RM
    Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
    Circulation. 2015;131:1019-30.
    PubMed     Text format    


  154. MARTINSSON A, Li X, Andersson C, Nilsson J, et al
    Temporal trends in the incidence and prognosis of aortic stenosis: a nationwide study of the Swedish population.
    Circulation. 2015;131:988-94.
    PubMed     Text format     Abstract available


  155. WEBBER SA, Hsu DT, Ivy DD, Kulik TJ, et al
    Task Force 7: Pediatric Cardiology Fellowship Training in Pulmonary Hypertension, Advanced Heart Failure, and Transplantation.
    Circulation. 2015 Mar 13. pii: CIR.0000000000000198.
    PubMed     Text format    


  156. LUBITZ SA, Yin X, Rienstra M, Schnabel RB, et al
    Long-Term Outcomes of Secondary Atrial Fibrillation in the Community: The Framingham Heart Study.
    Circulation. 2015 Mar 13. pii: CIRCULATIONAHA.114.014058.
    PubMed     Text format     Abstract available


  157. TAYLOR AL
    Racial differences and racial disparities: the distinction matters.
    Circulation. 2015;131:848-50.
    PubMed     Text format    


  158. HALLER C, Honjo O, Bradley T, Dragulescu A, et al
    Atresia of the ascending aorta in hypoplastic left heart syndrome.
    Circulation. 2015;131:925-6.
    PubMed     Text format    


  159. AMAT-SANTOS IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, et al
    Infective Endocarditis Following Transcatheter Aortic Valve Implantation: Results from a Large Multicenter Registry.
    Circulation. 2015 Mar 9. pii: CIRCULATIONAHA.114.014089.
    PubMed     Text format     Abstract available


  160. O'BRIEN P, Marshall AC
    Coarctation of the aorta.
    Circulation. 2015;131:e363-5.
    PubMed     Text format    


    February 2015
  161. SMITH SA, Sturm AC, Curran J, Kline CF, et al
    Dysfunction in the betaII spectrin-dependent cytoskeleton underlies human arrhythmia.
    Circulation. 2015;131:695-708.
    PubMed     Text format     Abstract available


  162. KILIC A, Higgins RS, Whitson BA, Kilic A, et al
    Racial Disparities in Outcomes of Adult Heart Transplantation.
    Circulation. 2015 Feb 11. pii: CIRCULATIONAHA.114.011676.
    PubMed     Text format     Abstract available


  163. BASURAY A, French B, Ky B, Vorovich E, et al
    Response to letter regarding article, "Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes".
    Circulation. 2015;131:e344.
    PubMed     Text format    


  164. PSATY BM, Shah SJ, Gottdiener J
    Letter by Psaty et al regarding article, "Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes".
    Circulation. 2015;131:e343.
    PubMed     Text format    


  165. WILKINS MR, Ghofrani HA, Weissmann N, Aldashev A, et al
    Pathophysiology and treatment of high-altitude pulmonary vascular disease.
    Circulation. 2015;131:582-90.
    PubMed     Text format    


    January 2015
  166. ZILE MR, Baicu CF, Ikonomidis J, Stroud RE, et al
    Myocardial Stiffness in Patients with Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin.
    Circulation. 2015 Jan 30. pii: CIRCULATIONAHA.114.013215.
    PubMed     Text format     Abstract available


  167. ALTMAN RB, Ashley EA
    Using "big data" to dissect clinical heterogeneity.
    Circulation. 2015;131:232-3.
    PubMed     Text format    


  168. SHAH AM
    Parsing the Role of Nox Enzymes and ROS in Heart Failure.
    Circulation. 2015 Jan 14. pii: CIRCULATIONAHA.115.014906.
    PubMed     Text format     Abstract available


    December 2014
  169. MOHAMMED SF, Hussain S, Mirzoyev SA, Edwards WD, et al
    Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2014 Dec 31. pii: CIRCULATIONAHA.114.009625.
    PubMed     Text format     Abstract available


  170. KITZMAN DW, Upadhya B, Vasu S
    What the Dead Can Teach the Living: The Systemic Nature of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2014 Dec 31. pii: CIRCULATIONAHA.114.014420.
    PubMed     Text format     Abstract available


  171. ZAMANI P, Rawat D, Shiva-Kumar P, Geraci S, et al
    The Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2014 Dec 22. pii: CIRCULATIONAHA.114.012957.
    PubMed     Text format     Abstract available


  172. VANDERPOOL R, Gladwin MT
    Harnessing the Nitrate-Nitrite-NO Pathway for Therapy of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2014 Dec 22. pii: CIRCULATIONAHA.114.014149.
    PubMed     Text format     Abstract available


  173. LI L, Chen Y, Doan J, Murray J, et al
    Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.
    Circulation. 2014;130:2162-72.
    PubMed     Text format     Abstract available


  174. MILLAR PJ, Murai H, Floras JS
    Paradoxical Muscle Sympathetic Reflex Activation in Human Heart Failure.
    Circulation. 2014 Dec 2. pii: CIRCULATIONAHA.114.010765.
    PubMed     Text format     Abstract available


  175. DUDZINSKI DM, Bhatt DL, Aragam JR, Maron BA, et al
    Explaining unexplained dyspnea: the ever "holesome" heart.
    Circulation. 2014;130:2057-66.
    PubMed     Text format    


  176. SENAGE T, Le Tourneau T, Foucher Y, Pattier S, et al
    Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
    Circulation. 2014;130:2012-20.
    PubMed     Text format     Abstract available


    November 2014
  177. KUBUS P, Materna O, Tax P, Tomek V, et al
    Successful permanent resynchronization for failing right ventricle after repair of tetralogy of Fallot.
    Circulation. 2014;130:e186-90.
    PubMed     Text format    


  178. KRUM H
    Prospective Comparison of ARNi With ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): Paragon of a Study or Further Investigation Paramount?
    Circulation. 2014 Nov 19. pii: CIRCULATIONAHA.114.013887.
    PubMed     Text format    


  179. ROSSIGNOL P, Zannad F
    Regional Differences in Heart Failure with Preserved Ejection Fraction Trials: When Nephrology Meets Cardiology but East Does not Meet West.
    Circulation. 2014 Nov 18. pii: CIRCULATIONAHA.114.013637.
    PubMed     Text format    


  180. KRISTENSEN SL, Kober L, Jhund PS, Solomon SD, et al
    International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction.
    Circulation. 2014 Nov 18. pii: CIRCULATIONAHA.114.012284.
    PubMed     Text format     Abstract available


  181. PFEFFER MA, Claggett B, Assmann SF, Boineau R, et al
    Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial.
    Circulation. 2014 Nov 18. pii: CIRCULATIONAHA.114.013255.
    PubMed     Text format     Abstract available


  182. PACKER M, McMurray JJ, Desai AS, Gong J, et al
    Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure.
    Circulation. 2014 Nov 17. pii: CIRCULATIONAHA.114.013748.
    PubMed     Text format     Abstract available


  183. TAQUETI VR, Hachamovitch R, Murthy VL, Naya M, et al
    Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization.
    Circulation. 2014 Nov 16. pii: CIRCULATIONAHA.114.011939.
    PubMed     Text format     Abstract available


  184. SHAH SJ, Katz DH, Selvaraj S, Burke MA, et al
    Phenomapping for Novel Classification of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2014 Nov 14. pii: CIRCULATIONAHA.114.010637.
    PubMed     Text format     Abstract available


  185. CHATTERJEE N, Steiner J, Lewis GD
    It's Time to Look at Heart Failure with Preserved Ejection Fraction from the Right Side.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.114.013536.
    PubMed     Text format     Abstract available


  186. MOHAMMED SF, Hussain I, Abou Ezzeddine OF, Takahama H, et al
    Right Ventricular Function in Heart Failure with Preserved Ejection Fraction: A Community Based Study.
    Circulation. 2014 Nov 12. pii: CIRCULATIONAHA.113.008461.
    PubMed     Text format     Abstract available


  187. RICH JD, Rich S
    Clinical diagnosis of pulmonary hypertension.
    Circulation. 2014;130:1820-30.
    PubMed     Text format    


  188. DROSATOS K, Schulze PC
    Savings precede spending: fatty acid utilization relies on triglyceride formation for cardiac energetics.
    Circulation. 2014;130:1775-7.
    PubMed     Text format    


  189. LAHEY R, Wang X, Carley AN, Lewandowski ED, et al
    Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Circulation. 2014;130:1790-9.
    PubMed     Text format     Abstract available


  190. TILLEY DG, Zhu W, Myers VD, Barr LA, et al
    beta-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.
    Circulation. 2014;130:1800-11.
    PubMed     Text format     Abstract available


  191. SHIH CJ, Chu H, Chao PW, Lee YJ, et al
    Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study.
    Circulation. 2014;130:1684-91.
    PubMed     Text format     Abstract available


    October 2014
  192. RUWALD MH, Solomon SD, Foster E, Kutyifa V, et al
    Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results from the MADIT-CRT Trial.
    Circulation. 2014 Oct 9. pii: CIRCULATIONAHA.114.011283.
    PubMed     Text format     Abstract available


  193. KREUSSER MM, Lehmann LH, Keranov S, Hoting MO, et al
    Cardiac CaM Kinase II genes delta and gamma contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
    Circulation. 2014;130:1262-73.
    PubMed     Text format     Abstract available


    September 2014
  194. SINNAEVE PR, Armstrong PW, Gershlick AH, Goldstein P, et al
    ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
    Circulation. 2014;130:1139-45.
    PubMed     Text format     Abstract available


  195. HORSTMAN MJ, Stewart DE, Naik AD
    Improving patients' postdischarge communication: making every word count.
    Circulation. 2014;130:1091-4.
    PubMed     Text format    


  196. TESTANI JM
    Renal subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): the end of nesiritide as a cardiorenal therapeutic?
    Circulation. 2014;130:936-8.
    PubMed     Text format    


  197. RUSSO AM
    Are we improving care of Medicare patients undergoing primary prevention implantable cardioverter-defibrillator implantation?
    Circulation. 2014;130:808-10.
    PubMed     Text format    


    August 2014
  198. SELVIN E, Lazo M, Chen Y, Shen L, et al
    Diabetes, Pre-Diabetes and Incidence of Subclinical Myocardial Damage.
    Circulation. 2014 Aug 22. pii: CIRCULATIONAHA.114.010815.
    PubMed     Text format     Abstract available


  199. BORNE RT, Peterson PN, Greenlee R, Heidenreich PA, et al
    Temporal Trends in Patient Characteristics and Outcomes Among Medicare Beneficiaries Undergoing Primary Prevention Implantable Cardioverter-Defibrillator Placement in the United States, 2006-2010: Results from the NCDR(R) ICD Registry.
    Circulation. 2014 Aug 5. pii: CIRCULATIONAHA.114.008653.
    PubMed     Text format     Abstract available


    July 2014
  200. SHIRAISHI I, Nishimura K, Sakaguchi H, Abe T, et al
    Acute Rupture of Chordae Tendineae of the Mitral Valve in Infants: A Nationwide Survey in Japan Exploring a New Syndrome.
    Circulation. 2014 Jul 25. pii: CIRCULATIONAHA.114.008592.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: